Inogen (INGN) News Today $9.91 -0.37 (-3.60%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$9.85 -0.06 (-0.61%) As of 02/21/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Inogen (INGN) Projected to Post Earnings on TuesdayInogen (NASDAQ:INGN) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=656223)February 18, 2025 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Short Interest UpdateInogen, Inc. (NASDAQ:INGN - Get Free Report) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 798,600 shares, an increase of 8.8% from the January 15th total of 734,000 shares. Based on an average daily volume of 224,800 shares, the days-to-cover ratio is presently 3.6 days.February 18, 2025 | marketbeat.comInogen (NASDAQ:INGN) Stock Price Crosses Above 200-Day Moving Average - Should You Sell?Inogen (NASDAQ:INGN) Share Price Crosses Above 200 Day Moving Average - What's Next?February 15, 2025 | marketbeat.comStockNews.com Upgrades Inogen (NASDAQ:INGN) to "Buy"February 12, 2025 | americanbankingnews.comAntea Group: Keith Knoke Appointed Chair of the Board of Directors for Inogen AllianceFebruary 11, 2025 | finanznachrichten.deInogen Alliance: Webinar: Understanding PFAS - Risks, Regulations, and Remedies - A Global PerspectiveFebruary 11, 2025 | finanznachrichten.deInogen (NASDAQ:INGN) Upgraded at StockNews.comStockNews.com raised shares of Inogen from a "hold" rating to a "buy" rating in a research note on Monday.February 10, 2025 | marketbeat.comInogen Board Reshuffle with Sahney AppointmentFebruary 3, 2025 | tipranks.comInogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in JanuaryInogen, Inc. (NASDAQ:INGN - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 714,200 shares, a drop of 6.2% from the December 31st total of 761,300 shares. Based on an average trading volume of 187,000 shares, the days-to-cover ratio is currently 3.8 days.February 1, 2025 | marketbeat.comInvestors in Inogen (NASDAQ:INGN) have unfortunately lost 75% over the last five yearsJanuary 31, 2025 | uk.finance.yahoo.comInogen (NASDAQ:INGN) Given "Hold" Rating at Needham & Company LLCNeedham & Company LLC reiterated a "hold" rating on shares of Inogen in a research note on Thursday.January 30, 2025 | marketbeat.comInogen’s Strategic Moves and Market Developments Lead to Hold Rating Amid Modest Near-Term Financial ImpactJanuary 29, 2025 | markets.businessinsider.comInogen enters strategic collaboration with Jiangsu Yuyue Medical EquipmentJanuary 27, 2025 | markets.businessinsider.comInogen Announces Strategic Collaboration with YuwellJanuary 27, 2025 | tipranks.comArab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory HealthJanuary 26, 2025 | investing.comArab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory HealthJanuary 26, 2025 | prnewswire.comInogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic ...January 26, 2025 | gurufocus.comInogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With YuwellJanuary 26, 2025 | investing.comAssenagon Asset Management S.A. Sells 160,429 Shares of Inogen, Inc. (NASDAQ:INGN)Assenagon Asset Management S.A. lowered its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 68.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 74,452 shares of the medical technology compJanuary 25, 2025 | marketbeat.comInogen Inc (INGN) Trading 4.31% Higher on Jan 24January 24, 2025 | gurufocus.comInogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in DecemberInogen, Inc. (NASDAQ:INGN - Get Free Report) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 714,200 shares, a drop of 6.2% from the December 15th total of 761,300 shares. Based on an average trading volume of 187,000 shares, the days-to-cover ratio is presently 3.8 days.January 19, 2025 | marketbeat.comCautious Hold Rating on Inogen Amid Mixed Growth Signals and Business ChallengesJanuary 14, 2025 | markets.businessinsider.comInogen reports preliminary Q4 revenue $79M, consensus $73.9MJanuary 14, 2025 | markets.businessinsider.comInogen’s Q4 Revenue Beat Overshadowed by Lack of Guidance, Earning a Hold RatingJanuary 14, 2025 | markets.businessinsider.comInogen Announces Preliminary Fourth Quarter and Full Year 2024 RevenueJanuary 14, 2025 | finance.yahoo.comInogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving Average - Here's WhyInogen (NASDAQ:INGN) Stock Price Crosses Above 50 Day Moving Average - Time to Sell?January 14, 2025 | marketbeat.comJane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN)Jane Street Group LLC lowered its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 83.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 50,927 shares of the medical technology company's stock after selling 250,473 shares duJanuary 6, 2025 | marketbeat.comInogen Expands U.S. Market with FDA ClearanceDecember 31, 2024 | markets.businessinsider.comInogen gets FDA 510(k) clearance for the SIMEOX 200 Airway Clearance DeviceDecember 31, 2024 | markets.businessinsider.comInogen Gets FDA Clearance for Airway Clearance DeviceDecember 30, 2024 | marketwatch.comInogen Secures FDA 510(k) Clearance For SIMEOX 200 Airway Clearance DeviceDecember 30, 2024 | markets.businessinsider.comInogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance DeviceDecember 30, 2024 | businesswire.comInogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78%December 21, 2024 | finance.yahoo.comStockNews.com Downgrades Inogen (NASDAQ:INGN) to HoldStockNews.com lowered Inogen from a "buy" rating to a "hold" rating in a report on Friday.December 20, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Sees Significant Growth in Short InterestInogen, Inc. (NASDAQ:INGN - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 794,700 shares, an increase of 6.7% from the November 15th total of 744,800 shares. Based on an average daily trading volume, of 192,900 shares, the short-interest ratio is currently 4.1 days.December 17, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Holdings Raised by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 312.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 174,625 shares of the medical technNovember 26, 2024 | marketbeat.comBrown Capital Management LLC Lowers Position in Inogen, Inc. (NASDAQ:INGN)Brown Capital Management LLC reduced its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 20.1% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,558,458 shares of the medical technology company's stock after selling 392,478 shares during the perNovember 21, 2024 | marketbeat.comShort Interest in Inogen, Inc. (NASDAQ:INGN) Declines By 11.4%Inogen, Inc. (NASDAQ:INGN - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 826,300 shares, a decline of 11.4% from the October 15th total of 932,600 shares. Based on an average daily volume of 190,100 shares, the days-to-cover ratio is currently 4.3 days.November 17, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comUS$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These ResultsNovember 10, 2024 | uk.finance.yahoo.comInogen, Inc. (INGN) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comInogen, Inc. Reports Third Quarter 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comNeedham Keeps Their Hold Rating on Inogen (INGN)November 9, 2024 | markets.businessinsider.comInogen, Inc. (INGN): A Bear Case TheoryNovember 8, 2024 | msn.comInogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC ChallengesNovember 8, 2024 | finance.yahoo.comInogen (NASDAQ:INGN) Earns "Hold" Rating from Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Inogen in a research report on Friday.November 8, 2024 | marketbeat.comInogen Inc (INGN) Q3 2024 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comInogen to Present at Upcoming Investor ConferencesNovember 6, 2024 | finance.yahoo.comInogen (INGN) Set to Announce Quarterly Earnings on ThursdayInogen (NASDAQ:INGN) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636745)October 31, 2024 | marketbeat.comInogen (NASDAQ:INGN) Stock Passes Below 200 Day Moving Average - Here's WhyInogen (NASDAQ:INGN) Stock Price Passes Below 200 Day Moving Average - Should You Sell?October 23, 2024 | marketbeat.com Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address INGN Media Mentions By Week INGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INGN News Sentiment▼0.890.60▲Average Medical News Sentiment INGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INGN Articles This Week▼32▲INGN Articles Average Week Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Establishment Labs News National Vision News Embecta News Bioventus News AxoGen News CeriBell News Avanos Medical News Iradimed News SI-BONE News Treace Medical Concepts News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INGN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
